MedPath

Comparison of low dose and high dose of furazolidone in the treatment of Helicobacter pylori infectio

Phase 3
Conditions
Helicobacterpylori Eradication.
Gastric ulcer
Registration Number
IRCT20160118026097N6
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
170
Inclusion Criteria

Peptic ulcer diagnosis with endoscopic diagnosis test
Helicobacter pylori infection with RUT
consent to cooperate

Exclusion Criteria

Pregnancy
Cancer or Liver Failure
Diabetes Mellitus
History of Cigarette
History of Alcohol
History of Drug Sensitivity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response to treatment-Helicobacter pylori eradication after drug treatment with urease respiratory test. Timepoint: Six weeks after drug treatment. Method of measurement: Urease Respiratory Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath